Oracle is to invest £150 million into next month’s IPO of Oxford Nanopore. The 16 year-old Oxford Nanopore provides pocketable kits to analyse RNA/DNA samples and supplies coronavirus testing kits to the NHS. The company is expected to be valued at £3 billion in the LSE IPO when it aims to raise £300 million. “Ever ...

This story continues at Oracle to invest in Oxford Nanopore IPO

Or just read more coverage at Electronics Weekly